14.01.2013 Views

Analytical Chemistry Chemical Cytometry Quantitates Superoxide

Analytical Chemistry Chemical Cytometry Quantitates Superoxide

Analytical Chemistry Chemical Cytometry Quantitates Superoxide

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Anal. Chem. 2010, 82, 6895–6903<br />

Electrophoretic Analysis of Biomarkers using<br />

Capillary Modification with Gold Nanoparticles<br />

Embedded in a Polycation and Boron Doped<br />

Diamond Electrode<br />

Lin Zhou, † Jeremy D. Glennon, † and John H. T. Luong* ,†,‡<br />

Innovative Chromatography Group, Irish Separation Science Cluster (ISSC), Department of <strong>Chemistry</strong> & the ABCRF,<br />

University College Cork, Cork, Ireland and Biotechnology Research Institute, National Research Council Canada,<br />

Montreal, Quebec, Canada H4P 2R2<br />

Field-amplified sample stacking using a fused silica<br />

capillary coated with gold nanoparticles (AuNPs) embedded<br />

in poly(diallyl dimethylammonium) chloride (PDDA)<br />

has been investigated for the electrophoretic separation<br />

of indoxyl sulfate, homovanillic acid (HVA), and vanillylmandelic<br />

acid (VMA). AuNPs (27 nm) exhibit ionic and<br />

hydrophobic interactions, as well as hydrogen bonding<br />

with the PDDA network to form a stable layer on the<br />

internal wall of the capillary. This approach reverses<br />

electro-osmotic flow allowing for fast migration of the<br />

analytes while retarding other endogenous compounds<br />

including ascorbic acid, uric acid, catecholamines, and<br />

indoleamines. Notably, the two closely related biomarkers<br />

of clinical significance, HVA and VMA, displayed differential<br />

interaction with PDDA-AuNPs which enabled the separation<br />

of this pair. The detection limit of the three analytes obtained<br />

by using a boron doped diamond electrode was ∼75 nM,<br />

which was significantly below their normal physiological<br />

levels in biological fluids. This combined separation and<br />

detection scheme was applied to the direct analysis of these<br />

analytes and other interfering chemicals including uric and<br />

ascorbic acids in urine samples without off-line sample<br />

treatment or preconcentration.<br />

Indoxyl sulfate (IXS), a metabolite of tryptophan (TRP) and a<br />

dietary protein, is derived from intestinal metabolism and liver<br />

conjugation 1 and excreted in urine in high concentration. It is also<br />

an endogenous compound in mammals, in mouse plasma and<br />

brain samples, as detected by liquid chromatography/tandem<br />

mass spectrometry. 2 This circulating protein-bound uremic toxin<br />

stimulates glomerular sclerosis, interstitial fibrosis, and the<br />

progression rate of renal failure. IXS induces endothelial dysfunction<br />

by inhibiting endothelial proliferation and migration in vitro<br />

* To whom correspondence should be addressed.<br />

† Innovative Chromatography Group, Irish Separation Science Cluster (ISSC),<br />

Department of <strong>Chemistry</strong> & the ABCRF, University College Cork.<br />

‡ Biotechnology Research Institute, National Research Council Canada.<br />

(1) Dealler, S. F.; Hawkey, P. M.; Millar, M. R. J. Clin. Microbiol. 1988, 26<br />

(10), 2152–2156.<br />

(2) Wang, G.-F.; Korfmacher, W. A. Rapid Commun. Mass Spectrom. 2008,<br />

23 (13), 2061–2069.<br />

and its role in oxidative stress is implicated. 3 Homovanillic acid<br />

(HVA) is a major catecholamine metabolite, associated with the<br />

brain dopamine level. As a biomarker of metabolic stress of<br />

2-deoxy-D-glucose, the HVA level in the brain and the cerebrospinal<br />

fluid is indicative of pheochromocytoma and neuoroblastoma. 4<br />

Metanephrine, one of the hormones produced by the adrenal<br />

glands, breaks down to normetanephrine and vanillylmandelic acid<br />

(VMA) via the intermediate 4-hydroxy-3-methoxy-phenylglycol.<br />

Thus, VMA is always detected in the urine together with HVA<br />

and other catecholamine metabolites from pheochromocytoma or<br />

catecholamine-secreting chromaffin tumor cells. 5,6 Catecholamine<br />

levels can be found in blood samples; however, the urine test<br />

reflects the production rate of the catecholamines over the<br />

collection period. Even at abnormal levels, the elevated quantities<br />

of these catecholamines are still very low, i.e., highly selective<br />

and sensitive analytical methods are needed for such important<br />

biomarkers. The urinary VMA and HVA values are most useful<br />

and can be correlated with the stage of disease, management, any<br />

maturation of tumor, and prognosis from children with neuroblastoma.<br />

4 The urine HVA/VMA ratio could be a screening tool<br />

to support earlier detection of Menkes disease, a disorder that<br />

affects copper levels in the body, leading to copper deficiency. 7a<br />

The mechanism that removes HVA from the brain is still poorly<br />

understood, however, the efflux transport of HVA from the brain<br />

plays an important role in controlling the HVA level in the brain.<br />

This HVA efflux transport system is inhibited by several organic<br />

anions including IXS, and metabolites of monoamine neurotransmitters<br />

but not neurotransmitters per se. 7b Thus, it is of clinical<br />

importance to develop a rapid and sensitive method for simultaneous<br />

analysis of HVA, VMA, and IXS in urine and other biological<br />

samples.<br />

(3) Tumur, Z.; Niwa, T. Am. J. Nephrol. 2009, 29, 551–557.<br />

(4) Liebner, E. J.; Rosenthal, I. M. Cancer 2006, 32 (3), 623–633.<br />

(5) Eisenhofer, G.; Lenders, J. W. M.; Linehan, W. M.; Walther, M. M.;<br />

Goldstein, D. S.; Keiser, H. R. New Engl. J. Med. 1999, 340, 1872–1879.<br />

(6) Lenders, J. W. M.; Keiser, H. R.; Goldstein, D. S.; Willemsen, J. J.; Friberg,<br />

P.; Jacobs, M.-C.; Kloppenborg, P. W. C.; Thien, T.; Eisenhofer, G. Ann.<br />

Intern. Med. 1995, 123, 101–109.<br />

(7) (a) Menkes, J. H.; Alter, M.; Steigleder, G. K.; Weakley, D. R.; Sung, J. H.<br />

Pediatrics 1962, 29, 764–779. (b) Mori, S.; Takanaga, H.; Ohtsuki, S.;<br />

Deguchi, T.; Kang, Y.-S.; Hosoya, K.-I.; Terasaki, T. J. Cereb. Blood Flow<br />

Metab. 2003, 23, 432–440.<br />

(8) (a) Issaq, H. J.; Delviks, K.; Janini, G. M.; Muschik, G. M. J. Liquid<br />

Chromatogr. Relat. Technol. 1992, 15/18, 3193–3201.<br />

10.1021/ac101105q © 2010 American <strong>Chemical</strong> Society 6895<br />

<strong>Analytical</strong> <strong>Chemistry</strong>, Vol. 82, No. 16, August 15, 2010<br />

Published on Web 07/16/2010

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!